Skip to main content
. Author manuscript; available in PMC: 2015 Mar 22.
Published in final edited form as: Cancer. 2011 Sep 12;118(2):321–325. doi: 10.1002/cncr.26284

Table 3.

Deleterious Breast Cancer Gene Mutations Identified in the Study Cohort

Identified Deleterious Mutations
BRCA1 BRCA2
3312insG 4075delGT
3509delA 5849del4
3600del11 6174delT
3875del4 6662del8
4154delA 6759del4
5194del4 7297delCT
5385insC 802delAT
943ins10 8513delC
C1251X 8568del4
C61G 886delGT
Del exon 17 9325insA
Del exons 1-17 9538delAA
Del exons 16-17 9631delC
Del exons 9-12 9663delGT
Dup exons 3-8 983del4
E1134X 9894delT
E1250X C2689X
E143X D2723H
E733X Del exons 1-2
Exon 13 ins 6kb
IVS13 + 1 G>A E1812X
IVS16+6T>G E49X
IVS20+1G>A K2013X
IVS23+1G>A Q2042X
K679X Q2957X
M1775R R2520X
Q1200X Y1655X
Q544X Y1894X
Q563X
R1443X
R1751X
S713X
S955X
Y1563X
Y978X

Abbreviations: A, alanine; BRCA, breast cancer gene; C, cysteine; D, aspartic acid; del, deletion; dup, duplication; E, glutamic acid; G, glycine; H, histidine; ins, insertion; IV, quadrivalent; M, methionine; Q, glutamine; R, arginine; S, serine; T, threonine; X, unspecified amino acid; Y, tyrosine.